Alan Maicon de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan Maicon de Oliveira has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Fabiana Rossi Varallo
Fabiana Rossi Varallo, Leonardo Régis Leira Pereira, and Maria Olívia Barboza Zanetti, Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of São Paulo at Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil
8 shared publications - Guilherme José Aguilar
Department of Chemistry, Faculty of Philosophy, Science and Letters at Ribeirão Preto
8 shared publications - Leonardo Régis Leira Pereira
Universidade de São Paulo, Brasil
8 shared publications Fabiana Rossi Varallo
School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto São Paulo Brazil
7 shared publications- João Paulo Vilela Rodrigues
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Ribeirão Preto (SP), Brasil
7 shared publications Leonardo Régis Leira Pereira
School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto São Paulo Brazil
6 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2201-2211
Instruments for assessing healthcare professionals’ knowledge, attitudes and practices regarding deprescribing: a scoping review
Introduction: Deprescribing is a multiprofessional process which aims to optimize medication use and improve patient safety, in which healthcare professionals' knowledge, attitudes, and practices (KAP) play a central role. The instruments used to assess KAP among nurses, pharmacists and physicians remain poorly characterised in terms of scope and measurement quality. Aim: To map and characterize the instruments used to assess healthcare professionals’ knowledge, attitudes, and practices regarding deprescribing. Method: A scoping review was conducted following Joaassess healthcaree (JBI) methodology and reported according to the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Primary studies were eligible if they involved nurses, pharmacists or physicians and applied any instrument assessing KAP related to deprescribing, individually or in combination, regardless of setting or country. Nine electronic databases were searched, including two grey literature sources were searched from inception to September 2024, without restrictions on language or publication date using terms related to nurses, pharmacists, physicians, deprescribing, surveys and questionnaires, and health knowledge, attitudes, and practice Study selection and data charting were performed independently by three pairs of reviewers using a standardised extraction form capturing study characteristics, instrument details, KAP domains assessed, and reported measurement properties. Data was synthesised using descriptive statistics and narrative analysis. The review protocol was registered on the Open Science Framework. Results: Of the 3,821 records screened, 49 met the inclusion criteria. Over two-thirds of the included studies were published since 2020 (n = 33, 67.3%). The evidence base was concentrated in high-income countries (n = 36/46, 78.0%; three multi-country studies were not classified by income level), particularly in the Europe and Central Asia region (n = 19, 41.0%), and most often focused solely on physicians, while studies simultaneously involving all three professional groups (physicians, pharmacists, and nurses) were less frequent (n = 8, 16.0%). Instruments commonly assessed multiple KAP domains, especially knowledge, attitudes, and practices combined (n = 12, 30.0%), whereas evidence on psychometric properties was reported in only a minority of studies (n = 13, 26.5%), among these, internal consistency and content validity were the pair most frequently reported together (n = 4, 31.0%). Conclusion: Instruments assessing healthcare professionals’ KAP regarding deprescribing remain limited in scope and psychometric robustness. Expanding interprofessional coverage and strengthening validation efforts are key priorities for advancing research in this field.
- 21 August 2026
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 48 (6) , 2201-2211
Open AccessInstruments for assessing healthcare professionals’ knowledge, attitudes and practices regarding deprescribing: a scoping review
Introduction: Deprescribing is a multiprofessional process which aims to optimize medication use and improve patient safety, in which healthcare professionals' knowledge, attitudes, and practices (KAP) play a central role. The instruments used to assess KAP among nurses, pharmacists and physicians remain poorly characterised in terms of scope and measurement quality. Aim: To map and characterize the instruments used to assess healthcare professionals’ knowledge, attitudes, and practices regarding deprescribing. Method: A scoping review was conducted following Joaassess healthcaree (JBI) methodology and reported according to the PRISMA Extension for Scoping Reviews (PRISMA-ScR). Primary studies were eligible if they involved nurses, pharmacists or physicians and applied any instrument assessing KAP related to deprescribing, individually or in combination, regardless of setting or country. Nine electronic databases were searched, including two grey literature sources were searched from inception to September 2024, without restrictions on language or publication date using terms related to nurses, pharmacists, physicians, deprescribing, surveys and questionnaires, and health knowledge, attitudes, and practice Study selection and data charting were performed independently by three pairs of reviewers using a standardised extraction form capturing study characteristics, instrument details, KAP domains assessed, and reported measurement properties. Data was synthesised using descriptive statistics and narrative analysis. The review protocol was registered on the Open Science Framework. Results: Of the 3,821 records screened, 49 met the inclusion criteria. Over two-thirds of the included studies were published since 2020 (n = 33, 67.3%). The evidence base was concentrated in high-income countries (n = 36/46, 78.0%; three multi-country studies were not classified by income level), particularly in the Europe and Central Asia region (n = 19, 41.0%), and most often focused solely on physicians, while studies simultaneously involving all three professional groups (physicians, pharmacists, and nurses) were less frequent (n = 8, 16.0%). Instruments commonly assessed multiple KAP domains, especially knowledge, attitudes, and practices combined (n = 12, 30.0%), whereas evidence on psychometric properties was reported in only a minority of studies (n = 13, 26.5%), among these, internal consistency and content validity were the pair most frequently reported together (n = 4, 31.0%). Conclusion: Instruments assessing healthcare professionals’ KAP regarding deprescribing remain limited in scope and psychometric robustness. Expanding interprofessional coverage and strengthening validation efforts are key priorities for advancing research in this field.
- Open Access
- 16 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (43) , 59032-59050
Advances in Eco-friendly Materials for Sustainable Packaging and Single-Use Utensils: A Decade of Innovation in Preparation, Characterization, and Applications
The demand for sustainable alternatives to synthetic plastics increases, driving research on developing eco-friendly packaging and single-use utensils. Unlike previous reviews, this work provides a critical synthesis of technological trends, identifying gaps that need to be filled and highlighting innovations that are reshaping the field, considering the scientific studies in the past decade. For this, we analyzed 5,744 articles published between 2013 and 2024, selected from 26,080 records retrieved in the Scopus database, through a scoping review aligned with the PRISMA-ScR checklist. Our findings reveal that research has been largely concentrated on films (over 90%), underscoring the need to develop other material types such as foams, cups, straws, and trays. Starch, cellulose, and poly(lactic acid) were the main raw materials with glycerol as the predominant plasticizer. Cross-linkers, fillers, and nanomaterials were incorporated to enhance mechanical, barrier, and functional properties─even though some of them are not biobased nor sustainable. Vegetable extracts and essential oils were used to impart active properties. Evaluations of biodegradability or disintegration, antimicrobial activity, and food preservation applications increased significantly between 2019-2024 compared to 2013-2018, demonstrating a shift toward multifunctional, application-oriented solutions and a growing demand for bioactive packaging. Overall, this review contributes by providing a comprehensive landscape of the field, highlighting the transition toward multifunctional, biodegradable, and innovative packages and utensils while emphasizing the challenges that must be overcome for broader industrial application.
- 16 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (43) , 59032-59050
Open AccessAdvances in Eco-friendly Materials for Sustainable Packaging and Single-Use Utensils: A Decade of Innovation in Preparation, Characterization, and Applications
The demand for sustainable alternatives to synthetic plastics increases, driving research on developing eco-friendly packaging and single-use utensils. Unlike previous reviews, this work provides a critical synthesis of technological trends, identifying gaps that need to be filled and highlighting innovations that are reshaping the field, considering the scientific studies in the past decade. For this, we analyzed 5,744 articles published between 2013 and 2024, selected from 26,080 records retrieved in the Scopus database, through a scoping review aligned with the PRISMA-ScR checklist. Our findings reveal that research has been largely concentrated on films (over 90%), underscoring the need to develop other material types such as foams, cups, straws, and trays. Starch, cellulose, and poly(lactic acid) were the main raw materials with glycerol as the predominant plasticizer. Cross-linkers, fillers, and nanomaterials were incorporated to enhance mechanical, barrier, and functional properties─even though some of them are not biobased nor sustainable. Vegetable extracts and essential oils were used to impart active properties. Evaluations of biodegradability or disintegration, antimicrobial activity, and food preservation applications increased significantly between 2019-2024 compared to 2013-2018, demonstrating a shift toward multifunctional, application-oriented solutions and a growing demand for bioactive packaging. Overall, this review contributes by providing a comprehensive landscape of the field, highlighting the transition toward multifunctional, biodegradable, and innovative packages and utensils while emphasizing the challenges that must be overcome for broader industrial application.
- Open Access
- 25 April 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (2)
Implementation of Pharmaceutical Care in Geriatrics: Strategies Adopted and Experiences Acquired
Objectives: To describe the steps, strategies adopted, and experiences accumulated during the implementation of pharmaceutical care in a geriatric ward. Method: A descriptive mixed-methods study was proposed, carried out in three planned stages for the implementation of pharmaceutical care (medication reconciliation, medication review, and pharmacotherapeutic follow-up) in a geriatric ward at the University of São Paulo Hospital. In the first stage, a scoping review was conducted using the EMBASE, Web of Science, and PubMed databases. The second stage consisted of developing a situational diagnosis of the ward and adjusting procedures. The third stage comprised an intervention method aimed at identifying and resolving drug-related problems and analyzing associated clinical outcomes. Results: In the first stage, after screening 3,640 articles on pharmaceutical interventions in geriatrics, 35 were included in the review. The interventions frequently used the STOPP/START criteria and the Beers criteria. The main barriers were the lack of specific training and restrictions on service continuity. This stage provided scientific support for project development. In the second stage, the situational diagnosis addressed the ward’s structure and epidemiological profile. Pharmaceutical services were validated by a multidisciplinary team and well accepted. In the third stage, 88% of patients had at least one PRP, with an average of 1.4 PRPs per patient. The acceptance rate of pharmaceutical recommendations was 85%. Conclusion: The planned method was effective in implementing pharmaceutical care, with the creation of informative materials and evidence-based strategies. Considering the context of geriatric wards, this initiative stands out as an innovation in a Latin American country and can serve as a model for similar initiatives.
- 25 April 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (2)
Open AccessImplementation of Pharmaceutical Care in Geriatrics: Strategies Adopted and Experiences Acquired
Objectives: To describe the steps, strategies adopted, and experiences accumulated during the implementation of pharmaceutical care in a geriatric ward. Method: A descriptive mixed-methods study was proposed, carried out in three planned stages for the implementation of pharmaceutical care (medication reconciliation, medication review, and pharmacotherapeutic follow-up) in a geriatric ward at the University of São Paulo Hospital. In the first stage, a scoping review was conducted using the EMBASE, Web of Science, and PubMed databases. The second stage consisted of developing a situational diagnosis of the ward and adjusting procedures. The third stage comprised an intervention method aimed at identifying and resolving drug-related problems and analyzing associated clinical outcomes. Results: In the first stage, after screening 3,640 articles on pharmaceutical interventions in geriatrics, 35 were included in the review. The interventions frequently used the STOPP/START criteria and the Beers criteria. The main barriers were the lack of specific training and restrictions on service continuity. This stage provided scientific support for project development. In the second stage, the situational diagnosis addressed the ward’s structure and epidemiological profile. Pharmaceutical services were validated by a multidisciplinary team and well accepted. In the third stage, 88% of patients had at least one PRP, with an average of 1.4 PRPs per patient. The acceptance rate of pharmaceutical recommendations was 85%. Conclusion: The planned method was effective in implementing pharmaceutical care, with the creation of informative materials and evidence-based strategies. Considering the context of geriatric wards, this initiative stands out as an innovation in a Latin American country and can serve as a model for similar initiatives.
- Open Access
- 22 April 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (2)
Implantação do Cuidado Farmacêutico na Geriatria: Estratégias Adotadas e Experiências Adquiridas
OBJETIVOS Descrever as etapas, as estratégias adotadas e as experiências acumuladas durante a implantação do cuidado farmacêutico em uma enfermaria de geriatria. MÉTODO Foi proposto um estudo de métodos mistos, descritivo, executado em três etapas planejadas para a implantação do cuidado farmacêutico (reconciliação de medicamentos, revisão da farmacoterapia e acompanhamento farmacoterapêutico) em uma enfermaria geriátrica do Hospital da Universidade de São Paulo. Na 1ª etapa, realizou-se uma revisão de escopo utilizando as bases EMBASE, Web of Science e PubMed. A 2ª etapa consistiu na elaboração do diagnóstico situacional da enfermaria e adequação dos procedimentos. A 3ª etapa compreendeu um método de intervenção visando identificar e resolver problemas relacionados à farmacoterapia (PRF). RESULTADOS Na 1ª etapa, após a triagem de 3.640 artigos sobre intervenções farmacêuticas em geriatria, 35 foram incluídos na revisão. As intervenções frequentemente usaram os critérios STOPP/START e os critérios de Beers. As principais barreiras foram a falta de treinamento específico e restrições à continuidade do serviço. Esta etapa forneceu embasamento científico para o desenvolvimento do projeto. Na 2ª etapa, o diagnóstico situacional abordou a estrutura da enfermaria e o perfil epidemiológico. Os serviços farmacêuticos foram validados por uma equipe multiprofissional e bem aceitos. Na 3ª etapa, 88% dos pacientes apresenta-ram pelo menos um PRF, com média de 1,4 PRF por paciente. A taxa de aceitação das recomendações farmacêuticas foi de 85%. CONCLUSÃO O método planejado mostrou se promissor na implantação do cuidado farmacêutico, com a criação de materiais informativos e estratégias baseadas em evidências. Considerando o contexto de enfermarias de geriatria, destaca-se como uma inovação em um país da América Latina e pode servir como modelo para iniciativas semelhantes.
- 22 April 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (2)
Open AccessImplantação do Cuidado Farmacêutico na Geriatria: Estratégias Adotadas e Experiências Adquiridas
OBJETIVOS Descrever as etapas, as estratégias adotadas e as experiências acumuladas durante a implantação do cuidado farmacêutico em uma enfermaria de geriatria. MÉTODO Foi proposto um estudo de métodos mistos, descritivo, executado em três etapas planejadas para a implantação do cuidado farmacêutico (reconciliação de medicamentos, revisão da farmacoterapia e acompanhamento farmacoterapêutico) em uma enfermaria geriátrica do Hospital da Universidade de São Paulo. Na 1ª etapa, realizou-se uma revisão de escopo utilizando as bases EMBASE, Web of Science e PubMed. A 2ª etapa consistiu na elaboração do diagnóstico situacional da enfermaria e adequação dos procedimentos. A 3ª etapa compreendeu um método de intervenção visando identificar e resolver problemas relacionados à farmacoterapia (PRF). RESULTADOS Na 1ª etapa, após a triagem de 3.640 artigos sobre intervenções farmacêuticas em geriatria, 35 foram incluídos na revisão. As intervenções frequentemente usaram os critérios STOPP/START e os critérios de Beers. As principais barreiras foram a falta de treinamento específico e restrições à continuidade do serviço. Esta etapa forneceu embasamento científico para o desenvolvimento do projeto. Na 2ª etapa, o diagnóstico situacional abordou a estrutura da enfermaria e o perfil epidemiológico. Os serviços farmacêuticos foram validados por uma equipe multiprofissional e bem aceitos. Na 3ª etapa, 88% dos pacientes apresenta-ram pelo menos um PRF, com média de 1,4 PRF por paciente. A taxa de aceitação das recomendações farmacêuticas foi de 85%. CONCLUSÃO O método planejado mostrou se promissor na implantação do cuidado farmacêutico, com a criação de materiais informativos e estratégias baseadas em evidências. Considerando o contexto de enfermarias de geriatria, destaca-se como uma inovação em um país da América Latina e pode servir como modelo para iniciativas semelhantes.
- 10 January 2025
- Published by Springer Nature in Journal of Medical Systems
- Vol. 49 (1) , 1-9
Contribution of Video Directly Observed Therapy (VDOT) to Tuberculosis Treatment in Brazil
Directly Observed Treatment (DOT) involves the administration of medication and in-person monitoring by a healthcare team alongside the patient to improve adherence to tuberculosis (TB) treatment. Implementing DOT requires healthcare professionals, transportation, time dedication, and presence at the patient’s residence. Meeting all these conditions is not always possible to address the high demand of TB patients who would benefit from this supervision. Video Directly Observed Therapy (VDOT) is a telecare platform created to remotely oversee the treatment of TB patients, allowing them to daily record medication intake, as prescribed, using their cell phones, clarify doubts, and facilitate communication with the healthcare team providing support. The medication intake data is recorded and accessible to healthcare professionals who monitor adherence remotely. The investigation reported in this work was conducted in Ribeirão Preto, Brazil, from May 5, 2020, to May 4, 2023, across five healthcare units. During the study period, 26,253 medication intake videos were collected and sent from 259 patients. Regarding the outcome reported by supervisors, only 9.7% of patients had their VDOT follow-up terminated due to abandonment, while the Cure/Treatment completion rate was 57.5%. Regarding adherence to the established treatment period for TB and for each patient in their specific situation, 67% of patients completed more than 66% of the treatment. The data suggested good acceptance of the system by both patients and healthcare professionals. VDOT may be a promising tool that complements TB DOT, extending its reach to improve adherence and reduce abandonment rates.
- 10 January 2025
- Published by Springer Nature in Journal of Medical Systems
- Vol. 49 (1) , 1-9
Contribution of Video Directly Observed Therapy (VDOT) to Tuberculosis Treatment in Brazil
Directly Observed Treatment (DOT) involves the administration of medication and in-person monitoring by a healthcare team alongside the patient to improve adherence to tuberculosis (TB) treatment. Implementing DOT requires healthcare professionals, transportation, time dedication, and presence at the patient’s residence. Meeting all these conditions is not always possible to address the high demand of TB patients who would benefit from this supervision. Video Directly Observed Therapy (VDOT) is a telecare platform created to remotely oversee the treatment of TB patients, allowing them to daily record medication intake, as prescribed, using their cell phones, clarify doubts, and facilitate communication with the healthcare team providing support. The medication intake data is recorded and accessible to healthcare professionals who monitor adherence remotely. The investigation reported in this work was conducted in Ribeirão Preto, Brazil, from May 5, 2020, to May 4, 2023, across five healthcare units. During the study period, 26,253 medication intake videos were collected and sent from 259 patients. Regarding the outcome reported by supervisors, only 9.7% of patients had their VDOT follow-up terminated due to abandonment, while the Cure/Treatment completion rate was 57.5%. Regarding adherence to the established treatment period for TB and for each patient in their specific situation, 67% of patients completed more than 66% of the treatment. The data suggested good acceptance of the system by both patients and healthcare professionals. VDOT may be a promising tool that complements TB DOT, extending its reach to improve adherence and reduce abandonment rates.
- Open Access
- 6 January 2025
- Published by University Nove de Julho in Revista de Gestão Ambiental e Sustentabilidade
- Vol. 14 (1) , 1-34
Analysis of intention to purchase environmentally friendly packaging in the city of Ribeirão Preto, Brazil
Objective: To evaluate consumers' intention to purchase biopackaging in the city of Ribeirão Preto, State of São Paulo, Brazil. Methodology: Structural equation modeling was assessed by applying a questionnaire to citizens in Ribeirão Preto. The constructs Personal Norms, Attitude, Environmental Concern, and Willingness to Pay were correlated with the construct Purchase Intention, and the structural model was analyzed. Originality/Relevance: This study stands out for its originality in investigating how certain factors affect consumers’ intention to purchase environmentally friendly packaging in Ribeirão Preto as a specific case study in Brazil. Given that few studies have addressed such topic in this country, the study aims to contribute to the research field significantly. Results: All the constructs positively influenced the construct Purchase Intention, but Environmental Concern and Personal Norms were the strongest predictors of this intention (standardized regression coefficients of 0.821 and 0.818, respectively; p ≤ 0.01). Social/Management Contributions: Broader ecological awareness is promoted within the society when companies are encouraged to develop new biodegradable and environmentally friendly packaging that meets consumers' needs and considers environmental demands. In the management context, emphasizing how the constructs positively influence purchase intention highlights specific areas on which organizations can focus when they develop and market sustainable packaging. It is hoped that the study will encourage companies to embrace sustainable development and to align their products with the consumers’ growing expectations about sustainability, green consumption, and social and ecological responsibility.
- 6 January 2025
- Published by University Nove de Julho in Revista de Gestão Ambiental e Sustentabilidade
- Vol. 14 (1) , 1-34
Open AccessAnalysis of intention to purchase environmentally friendly packaging in the city of Ribeirão Preto, Brazil
Objective: To evaluate consumers' intention to purchase biopackaging in the city of Ribeirão Preto, State of São Paulo, Brazil. Methodology: Structural equation modeling was assessed by applying a questionnaire to citizens in Ribeirão Preto. The constructs Personal Norms, Attitude, Environmental Concern, and Willingness to Pay were correlated with the construct Purchase Intention, and the structural model was analyzed. Originality/Relevance: This study stands out for its originality in investigating how certain factors affect consumers’ intention to purchase environmentally friendly packaging in Ribeirão Preto as a specific case study in Brazil. Given that few studies have addressed such topic in this country, the study aims to contribute to the research field significantly. Results: All the constructs positively influenced the construct Purchase Intention, but Environmental Concern and Personal Norms were the strongest predictors of this intention (standardized regression coefficients of 0.821 and 0.818, respectively; p ≤ 0.01). Social/Management Contributions: Broader ecological awareness is promoted within the society when companies are encouraged to develop new biodegradable and environmentally friendly packaging that meets consumers' needs and considers environmental demands. In the management context, emphasizing how the constructs positively influence purchase intention highlights specific areas on which organizations can focus when they develop and market sustainable packaging. It is hoped that the study will encourage companies to embrace sustainable development and to align their products with the consumers’ growing expectations about sustainability, green consumption, and social and ecological responsibility.
- 22 December 2024
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (3) , 729-739
Strategies employed and experiences associated with the implementation of pharmaceutical services and interventions in geriatric wards: A scoping review
Evidence indicates a lack of clarity regarding the contributions of interventions aimed at optimizing pharmacotherapy, primarily guided by pharmaceutical care, for clinically significant improvements in older individuals. Thus, there is a need to deepen the understanding of this scenario and the factors involved. Therefore, this study aims to map and summarize scientific evidence regarding experiences and strategies employed in providing pharmaceutical services and interventions in geriatric wards. A scoping review was conducted based on 3 electronic databases (PubMed, EMBASE and Web of Science). Studies meeting the inclusion criteria, published up to September 2024, and in English, Spanish or Portuguese were selected. Experimental and observational studies were eligible for inclusion. Screening, eligibility, extraction and assessment of the studies were carried out by 2 independent researchers. The exploration of bibliographic databases yielded 3,976 references, and 40 studies were deemed suitable for inclusion. Predominantly conducted in countries with high human development, these studies categorized services and interventions as: (i) medication review; (ii) medication reconciliation; and (iii) pharmaceutical counselling. Highlighted tools included STOPP and START criteria, Beers criteria, and the Medication Appropriateness Index, facilitating identification of issues such as potentially inappropriate medications (27.6–90.8% of older individuals using at least 1 potentially inappropriate medication), drug‐related problems (34.5–98.2% of patients with at least 1 drug‐related problem) and adverse drug events (58–88.4% of patients with at least 1 adverse drug event). The acceptance rate of interventions exhibited considerable variation (13–95.3%). Only 10 studies evaluated clinical outcomes in patients. Barriers included the need for additional training for pharmacists in geriatrics, significant time investment, lack of continuity in assessments and a lack of recognition of interventions by other members of the multiprofessional team. There is a clear trend towards improving medication prescription adequacy and contributing to the quality of pharmacotherapy through pharmaceutical services and interventions in geriatric wards. However, several gaps still need to be addressed, and this review emphasizes identifying obstacles to be overcome, providing guidance for future investigations.
- 22 December 2024
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (3) , 729-739
Strategies employed and experiences associated with the implementation of pharmaceutical services and interventions in geriatric wards: A scoping review
Evidence indicates a lack of clarity regarding the contributions of interventions aimed at optimizing pharmacotherapy, primarily guided by pharmaceutical care, for clinically significant improvements in older individuals. Thus, there is a need to deepen the understanding of this scenario and the factors involved. Therefore, this study aims to map and summarize scientific evidence regarding experiences and strategies employed in providing pharmaceutical services and interventions in geriatric wards. A scoping review was conducted based on 3 electronic databases (PubMed, EMBASE and Web of Science). Studies meeting the inclusion criteria, published up to September 2024, and in English, Spanish or Portuguese were selected. Experimental and observational studies were eligible for inclusion. Screening, eligibility, extraction and assessment of the studies were carried out by 2 independent researchers. The exploration of bibliographic databases yielded 3,976 references, and 40 studies were deemed suitable for inclusion. Predominantly conducted in countries with high human development, these studies categorized services and interventions as: (i) medication review; (ii) medication reconciliation; and (iii) pharmaceutical counselling. Highlighted tools included STOPP and START criteria, Beers criteria, and the Medication Appropriateness Index, facilitating identification of issues such as potentially inappropriate medications (27.6–90.8% of older individuals using at least 1 potentially inappropriate medication), drug‐related problems (34.5–98.2% of patients with at least 1 drug‐related problem) and adverse drug events (58–88.4% of patients with at least 1 adverse drug event). The acceptance rate of interventions exhibited considerable variation (13–95.3%). Only 10 studies evaluated clinical outcomes in patients. Barriers included the need for additional training for pharmacists in geriatrics, significant time investment, lack of continuity in assessments and a lack of recognition of interventions by other members of the multiprofessional team. There is a clear trend towards improving medication prescription adequacy and contributing to the quality of pharmacotherapy through pharmaceutical services and interventions in geriatric wards. However, several gaps still need to be addressed, and this review emphasizes identifying obstacles to be overcome, providing guidance for future investigations.
- 16 December 2024
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (1) , e14276
Development and Content Analysis Protocol for Evaluating Artificial Intelligence in Drug‐Related Information
Introduction: Artificial intelligence (AI) has significant transformative potential across various sectors, particularly in health care. This study aims to develop a protocol for the content analysis of a method designed to assess AI applications in drug‐related information, specifically focusing on contraindications, adverse reactions, and drug interactions. By addressing existing challenges, this preliminary research seeks to enhance the safe and reliable integration of AI into healthcare practices.Methods: A study protocol was developed for the creation of the method, followed by an initial content analysis conducted by an expert panel. The method was established in phases: (1) Analysis of drug‐related databases and form development; (2) AI configuration; (3) Expert panel review and initial validation.Results: In Phase 1, the Micromedex, UpToDate, and Medscape databases were reviewed to establish terminology and classifications related to contraindications, adverse reactions, and drug interactions, resulting in the development of a questionnaire for the AI. Phase 2 involved configuring the Gemini AI tool to enhance response specificity. In Phase 3, AI responses to 30 questions were validated by an expert panel, yielding a 76.7% agreement rate for appropriateness, while 23.3% were deemed inappropriate, particularly concerning contraindicated drug interactions.Conclusion: This preliminary study demonstrates the potential for using an AI‐powered tool to standardize drug‐related information retrieval, particularly for contraindications and adverse reactions. While AI responses were generally appropriate, improvements are needed in identifying contraindicated drug interactions. Further research with larger datasets and broader evaluations is required to enhance AI's reliability in healthcare settings.
- 16 December 2024
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (1) , e14276
Development and Content Analysis Protocol for Evaluating Artificial Intelligence in Drug‐Related Information
Introduction: Artificial intelligence (AI) has significant transformative potential across various sectors, particularly in health care. This study aims to develop a protocol for the content analysis of a method designed to assess AI applications in drug‐related information, specifically focusing on contraindications, adverse reactions, and drug interactions. By addressing existing challenges, this preliminary research seeks to enhance the safe and reliable integration of AI into healthcare practices.Methods: A study protocol was developed for the creation of the method, followed by an initial content analysis conducted by an expert panel. The method was established in phases: (1) Analysis of drug‐related databases and form development; (2) AI configuration; (3) Expert panel review and initial validation.Results: In Phase 1, the Micromedex, UpToDate, and Medscape databases were reviewed to establish terminology and classifications related to contraindications, adverse reactions, and drug interactions, resulting in the development of a questionnaire for the AI. Phase 2 involved configuring the Gemini AI tool to enhance response specificity. In Phase 3, AI responses to 30 questions were validated by an expert panel, yielding a 76.7% agreement rate for appropriateness, while 23.3% were deemed inappropriate, particularly concerning contraindicated drug interactions.Conclusion: This preliminary study demonstrates the potential for using an AI‐powered tool to standardize drug‐related information retrieval, particularly for contraindications and adverse reactions. While AI responses were generally appropriate, improvements are needed in identifying contraindicated drug interactions. Further research with larger datasets and broader evaluations is required to enhance AI's reliability in healthcare settings.
- Open Access
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Implantação de práticas relacionadas ao cuidado farmacêutico na geriatria: estratégias adotadas e experiências adquiridas
Introdução: Evidências indicam a necessidade de avaliar os desfechos clínicos e monitorar o cuidado farmacêutico empopulações vulneráveis a problemas relacionados à farmacoterapia (PRF)1-3, aspectos cruciais para incentivar a implantação do cuidado farmacêutico nos serviços de saúde4,5.Objetivos: Implantar o cuidado farmacêutico (reconciliação de medicamentos, revisão da farmacoterapia e acompanhamento farmacoterapêutico) em uma enfermaria geriátrica do Hospital da Universidade de São Paulo, executando-o em quatro etapas planejadas. Material e Método: Na 1ª etapa, realizou-se uma revisão de escopo utilizando as bases PubMed, EMBASE e Web of Science, seguindo a metodologia do Joanna Briggs Institute e o checklist PRISMA-ScR. A 2ª etapa consistiu no desenvolvimento do Manual da Prática do Cuidado Farmacêutico na Geriatria (MaPCFarmaGeri), dividido em diagnóstico situacional e adequação do procedimento. A 3ª etapa compreendeu um ensaio clínico de braço único realizado entre janeiro e maio de 2022, com acompanhamento por até 90 dias pós-alta, visando identificar e resolver PRF e analisar desfechos clínicos associados. A 4ª etapa focou na promoção da educação em saúde durante a internação, com a introdução de materiais educativos e intervenções individualizadas. O projeto foi registrado na plataforma Registro Brasileiro de Ensaios Clínicos (RBR-34f2px4) e aprovado pelo Comitê de Ética (CAAE: 99298718.1.000.5403). Resultados: Na 1ª etapa, após a triagem de 3.640 artigos sobre intervenções farmacêuticas em geriatria, 35 foram incluídos na revisão. As intervenções frequentemente usaram os critérios STOPP/START e os critérios de Beers. As principais barreiras foram a falta de treinamento específico e restrições à continuidade do serviço. Esta etapa forneceu embasamento científico para o desenvolvimento do projeto. Na 2ª etapa, o diagnóstico situacional abordou a estrutura da enfermaria e o perfil epidemiológico. Os serviços farmacêuticos foram validados por uma equipe multiprofissional e bem aceitos. O MaP-CFarmaGeri mostrou-se efetivo na implementação do cuidado farmacêutico. Na 3ª etapa, 88,3% dos pacientes apresentaram pelo menos um PRF, com média de 2,6 PRF por paciente. Polifarmácia e multimorbidade aumentaram as chances de PRF (p=0,03). A aceitação das recomendações foi de 80,9%, e a polifarmácia cessou em 23,6% dos pacientes na alta. Ocorreram 16 óbitos e 23 readmissões em até 90 dias. Na 4ª etapa, foram desenvolvidas técnicas para promover a adesão à farmacoterapia e educação em saúde para idosos com polifarmácia e multimorbidade. Medidas para aumentar a autonomia dos pacientes incluíram, por exemplo, a entrega de bolsas e listas educativas para o armazenamento e uso correto dos medicamentos. Discussão e Conclusões: O método planejado foi efetivo na implantação do cuidado farmacêutico, com a criação de materiais informativos e estratégias baseadas em evidências. Destaca-se como uma inovação em um país da América Latina e pode servir como modelo para iniciativas em contextos semelhantes.
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Open AccessImplantação de práticas relacionadas ao cuidado farmacêutico na geriatria: estratégias adotadas e experiências adquiridas
Introdução: Evidências indicam a necessidade de avaliar os desfechos clínicos e monitorar o cuidado farmacêutico empopulações vulneráveis a problemas relacionados à farmacoterapia (PRF)1-3, aspectos cruciais para incentivar a implantação do cuidado farmacêutico nos serviços de saúde4,5.Objetivos: Implantar o cuidado farmacêutico (reconciliação de medicamentos, revisão da farmacoterapia e acompanhamento farmacoterapêutico) em uma enfermaria geriátrica do Hospital da Universidade de São Paulo, executando-o em quatro etapas planejadas. Material e Método: Na 1ª etapa, realizou-se uma revisão de escopo utilizando as bases PubMed, EMBASE e Web of Science, seguindo a metodologia do Joanna Briggs Institute e o checklist PRISMA-ScR. A 2ª etapa consistiu no desenvolvimento do Manual da Prática do Cuidado Farmacêutico na Geriatria (MaPCFarmaGeri), dividido em diagnóstico situacional e adequação do procedimento. A 3ª etapa compreendeu um ensaio clínico de braço único realizado entre janeiro e maio de 2022, com acompanhamento por até 90 dias pós-alta, visando identificar e resolver PRF e analisar desfechos clínicos associados. A 4ª etapa focou na promoção da educação em saúde durante a internação, com a introdução de materiais educativos e intervenções individualizadas. O projeto foi registrado na plataforma Registro Brasileiro de Ensaios Clínicos (RBR-34f2px4) e aprovado pelo Comitê de Ética (CAAE: 99298718.1.000.5403). Resultados: Na 1ª etapa, após a triagem de 3.640 artigos sobre intervenções farmacêuticas em geriatria, 35 foram incluídos na revisão. As intervenções frequentemente usaram os critérios STOPP/START e os critérios de Beers. As principais barreiras foram a falta de treinamento específico e restrições à continuidade do serviço. Esta etapa forneceu embasamento científico para o desenvolvimento do projeto. Na 2ª etapa, o diagnóstico situacional abordou a estrutura da enfermaria e o perfil epidemiológico. Os serviços farmacêuticos foram validados por uma equipe multiprofissional e bem aceitos. O MaP-CFarmaGeri mostrou-se efetivo na implementação do cuidado farmacêutico. Na 3ª etapa, 88,3% dos pacientes apresentaram pelo menos um PRF, com média de 2,6 PRF por paciente. Polifarmácia e multimorbidade aumentaram as chances de PRF (p=0,03). A aceitação das recomendações foi de 80,9%, e a polifarmácia cessou em 23,6% dos pacientes na alta. Ocorreram 16 óbitos e 23 readmissões em até 90 dias. Na 4ª etapa, foram desenvolvidas técnicas para promover a adesão à farmacoterapia e educação em saúde para idosos com polifarmácia e multimorbidade. Medidas para aumentar a autonomia dos pacientes incluíram, por exemplo, a entrega de bolsas e listas educativas para o armazenamento e uso correto dos medicamentos. Discussão e Conclusões: O método planejado foi efetivo na implantação do cuidado farmacêutico, com a criação de materiais informativos e estratégias baseadas em evidências. Destaca-se como uma inovação em um país da América Latina e pode servir como modelo para iniciativas em contextos semelhantes.
- Open Access
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Aprimorando o tratamento da tuberculose no Brasil: o impacto da Terapia Observada por Vídeo (VDOT) em desfechos clínicos, humanísticos e econômicos
Introdução: O Tratamento Diretamente Observado (TDO) envolve a administração de medicamentos e o monitoramentopresencial por uma equipe de saúde junto ao paciente para melhorar a adesão ao tratamento da tuberculose (TB). Implementar o TDO exige necessidades e gastos com transporte, dedicação de tempo e a presença de um profissional de saúde na residência do paciente1-3. Atender a todas essas condições nem sempre é possível, devido à alta demanda de pacientes com TB que se beneficiariam dessa supervisão4. Objetivo: Descrever o desenvolvimento de uma plataforma digital para o monitoramento do tratamento da TB por vídeo e analisar os desfechos de três anos de uso desta plataforma em uma cidade brasileira com prevalência significativa de TB. Material e Método: O “Video Directly Observed Treatment” (VDOT) é uma plataforma de telessaúde criada por pesquisadores da Universidade de São Paulo para supervisionar remotamente a farmacoterapia de pacientes com TB. A plataforma permite que os pacientes gravem diariamente a ingestão dos medicamentos usando seus celulares, esclareçam dúvidas e facilitem a comunicação com a equipe de saúde que oferece suporte. Os dados sobre a farmacoterapia são registrados e acessíveis aos profissionais de saúde que monitoram a adesão remotamente. A cidade de Ribeirão Preto (SP), no Brasil, foi escolhida como local para o estudo do VDOT, iniciado em março de 2020 em cinco unidades de saúde. Após o treinamento das equipes, o acompanhamento foi realizado por três anos. O estudo foi aprovado pelo Comitê de Ética em Pesquisa (CAAE: 75761617.2.0000.5440). Resultados: Durante o período do estudo, foram coletados e enviados 26.253 vídeos de acompanhamento da farmacoterapia de 259 pacientes. Quanto ao desfecho relatado pelos cuidadores, apenas 9,7% dos pacientes tiveram seu acompanhamento pelo VDOT interrompido devido ao abandono, enquanto a taxa de cura/conclusão do tratamento foi de 57,5%. Entre os tratamentos monitorados remotamente, apenas 8,1% dos pacientes tiveram menos de 32% dos vídeos esperados validados, e 91,9% tiveram o acompanhamento mínimo recomendado pela Organização Mundial da Saúde (OMS). A economia estimada para um tratamento completo pelo sistema de saúde foi de 1:11, ou seja, para cada 1 real investido no VDOT, economiza-se R$11. A mensuração pelo índice de satisfação Net Promoter Score (NPS) recebeu a nota máxima. Além disso, foi observada uma boa aceitação do sistema tanto por pacientes quanto por profissionais de saúde. Conclusões: O VDOT é uma ferramenta promissora complementar ao TDO em pacientes com TB. Com esse recurso, é possível expandir o alcance do TDO, maximizando seus efeitos na adesão e reduzindo as taxas de abandono. O VDOT está sendo atualizado e há planos para expandir seu uso para outras cidades, bem como para o tratamento de outras enfermidades. O VDOT foi eleito pela OMS (em 2021) como uma das melhores iniciativas mundiais na luta contra a TB no contexto da COVID-193.
- 10 December 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (s. 3)
Open AccessAprimorando o tratamento da tuberculose no Brasil: o impacto da Terapia Observada por Vídeo (VDOT) em desfechos clínicos, humanísticos e econômicos
Introdução: O Tratamento Diretamente Observado (TDO) envolve a administração de medicamentos e o monitoramentopresencial por uma equipe de saúde junto ao paciente para melhorar a adesão ao tratamento da tuberculose (TB). Implementar o TDO exige necessidades e gastos com transporte, dedicação de tempo e a presença de um profissional de saúde na residência do paciente1-3. Atender a todas essas condições nem sempre é possível, devido à alta demanda de pacientes com TB que se beneficiariam dessa supervisão4. Objetivo: Descrever o desenvolvimento de uma plataforma digital para o monitoramento do tratamento da TB por vídeo e analisar os desfechos de três anos de uso desta plataforma em uma cidade brasileira com prevalência significativa de TB. Material e Método: O “Video Directly Observed Treatment” (VDOT) é uma plataforma de telessaúde criada por pesquisadores da Universidade de São Paulo para supervisionar remotamente a farmacoterapia de pacientes com TB. A plataforma permite que os pacientes gravem diariamente a ingestão dos medicamentos usando seus celulares, esclareçam dúvidas e facilitem a comunicação com a equipe de saúde que oferece suporte. Os dados sobre a farmacoterapia são registrados e acessíveis aos profissionais de saúde que monitoram a adesão remotamente. A cidade de Ribeirão Preto (SP), no Brasil, foi escolhida como local para o estudo do VDOT, iniciado em março de 2020 em cinco unidades de saúde. Após o treinamento das equipes, o acompanhamento foi realizado por três anos. O estudo foi aprovado pelo Comitê de Ética em Pesquisa (CAAE: 75761617.2.0000.5440). Resultados: Durante o período do estudo, foram coletados e enviados 26.253 vídeos de acompanhamento da farmacoterapia de 259 pacientes. Quanto ao desfecho relatado pelos cuidadores, apenas 9,7% dos pacientes tiveram seu acompanhamento pelo VDOT interrompido devido ao abandono, enquanto a taxa de cura/conclusão do tratamento foi de 57,5%. Entre os tratamentos monitorados remotamente, apenas 8,1% dos pacientes tiveram menos de 32% dos vídeos esperados validados, e 91,9% tiveram o acompanhamento mínimo recomendado pela Organização Mundial da Saúde (OMS). A economia estimada para um tratamento completo pelo sistema de saúde foi de 1:11, ou seja, para cada 1 real investido no VDOT, economiza-se R$11. A mensuração pelo índice de satisfação Net Promoter Score (NPS) recebeu a nota máxima. Além disso, foi observada uma boa aceitação do sistema tanto por pacientes quanto por profissionais de saúde. Conclusões: O VDOT é uma ferramenta promissora complementar ao TDO em pacientes com TB. Com esse recurso, é possível expandir o alcance do TDO, maximizando seus efeitos na adesão e reduzindo as taxas de abandono. O VDOT está sendo atualizado e há planos para expandir seu uso para outras cidades, bem como para o tratamento de outras enfermidades. O VDOT foi eleito pela OMS (em 2021) como uma das melhores iniciativas mundiais na luta contra a TB no contexto da COVID-193.